{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:29:09Z","timestamp":1777994949809,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ad.2024.11.015","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T10:01:35Z","timestamp":1732010495000},"page":"T141-T146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Psoriatic Patient-Reported Outcomes, Adherence, and Satisfaction"],"prefix":"10.1016","volume":"116","author":[{"given":"J.","family":"Perales Pascual","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Navarro Azn\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"L\u00f3pez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gracia-Caza\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Gilaberte Calzada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa R.","family":"Abad Sazatornil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2024.11.015_bib0135","unstructured":"European Medicines Agency. Committee for medicinal products for human use. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the D Doc. Ref. EMA\/CHMP\/EWP\/139391\/2004. London: EMA; 2005. Available from: https:\/\/es.scribd.com\/document\/688259282\/reflection-paper-regulatory-guidance-use-health-related-quality-life-hrql-measures-evaluation-en [accessed September 2022]."},{"key":"10.1016\/j.ad.2024.11.015_bib0140","unstructured":"Grupo de Trabajo de Psoriasis de la AEDV. Calidad de vida y psoriasis. Available from: https:\/\/aedv.es\/wp-content\/uploads\/2016\/07\/Calidad-de-vida-y-psoriasis.pdf [accessed September 2022]."},{"key":"10.1016\/j.ad.2024.11.015_bib0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaad.2014.05.001","article-title":"Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting","volume":"71","author":"Takeshita","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2024.11.015_bib0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ad.2019.02.009","article-title":"Instrumentos para la valoraci\u00f3n de los resultados percibidos por el paciente con psoriasis en Espa\u00f1a: revisi\u00f3n sistem\u00e1tica de la literatura","volume":"110","author":"Liz\u00e1n","year":"2019","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2024.11.015_bib0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ad.2010.03.028","article-title":"Dise\u00f1o y validaci\u00f3n de un cuestionario para medir la satisfacci\u00f3n con el tratamiento del paciente con psoriasis moderada y grave: estudio NEODERMA","volume":"102","author":"Ribera","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2024.11.015_bib0160","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ad.2013.12.008","article-title":"Prevelancia de la psoriasis en Espa\u00f1a en la era de los agentes biol\u00f3gicos","volume":"105","author":"Ferrandiz","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2024.11.015_bib0165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.clindermatol.2007.08.007","article-title":"Psoriasis: epidemiology","volume":"25","author":"Gudjonsson","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ad.2024.11.015_bib0170","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ad.2017.07.002","article-title":"Psoriasis moderada. Propuesta de definici\u00f3n","volume":"108","author":"Llamas-Velasco","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2024.11.015_bib0175","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ad.2018.03.029","article-title":"PASI absoluto versus PASI relativo en la pr\u00e1ctica cl\u00ednica real","volume":"110","author":"Alc\u00e1zar Viladomiu","year":"2019","journal-title":"Actas Dermosifilogr"},{"key":"10.1016\/j.ad.2024.11.015_bib0180","series-title":"Adherencia al tratamiento de la psoriasis en pacientes espa\u00f1oles","first-page":"8","author":"Leal Canosa","year":"2013"},{"key":"10.1016\/j.ad.2024.11.015_bib0185","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1157\/13125407","article-title":"Revisi\u00f3n de tests de medici\u00f3n del cumplimiento terap\u00e9utico utilizados en la pr\u00e1ctica cl\u00ednica","volume":"40","author":"Rodr\u00edguez Chamorro","year":"2018","journal-title":"Aten Primaria"},{"key":"10.1016\/j.ad.2024.11.015_bib0190","unstructured":"Grupo de expertos de la Secretar\u00eda del Plan Nacional sobre el Sida (SPNS), Grupo de Estudio de Sida (GeSIDA) y Sociedad Espa\u00f1ola de Farmacia Hospitalaria (SEFH). Documento de consenso para mejorar la adherencia a la farmacoterapia en pacientes con infecci\u00f3n por el virus de la inmunodeficiencia humana en tratamiento antirretroviral. 2020. Available from: https:\/\/www.sanidad.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/publicaciones\/profSanitarios\/docAdherencia_actualizacionFeb20.pdf [accessed January 2023]."},{"key":"10.1016\/j.ad.2024.11.015_bib0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ad.2010.03.028","article-title":"Dise\u00f1o y validaci\u00f3n de un cuestionario para medir la satisfacci\u00f3n en el tratamiento del paciente con psoriasis moderada y grave: NEODERMA","volume":"102","author":"Ribera","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2024.11.015_bib0200","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.0022-202X.2005.23775.x","article-title":"The psychometric properties of the Psoriasis Disability Index in United States patients","volume":"125","author":"Nijsten","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2024.11.015_bib0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.2011.10583.x","article-title":"Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials","volume":"166","author":"Reich","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2024.11.015_bib0210","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ad.2012.04.005","article-title":"Evaluaci\u00f3n cl\u00ednica y terap\u00e9utica de los pacientes con psoriasis moderada o grave en Espa\u00f1a: el estudio de secuencia","volume":"103","author":"Hern\u00e1nz","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2024.11.015_bib0215","unstructured":"Bernab\u00e9u Mart\u00ednez MA. Abordaje integral del paciente con psoriasis. Atenci\u00f3n farmac\u00e9utica a pacientes externos. Available from: https:\/\/svfh.es\/wp-content\/uploads\/2020\/11\/MODULO-4.-Abordaje-integral-d-el-paciente-con-psoriasis.pdf [accessed March 2023]."},{"key":"10.1016\/j.ad.2024.11.015_bib0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2133.2008.08865.x","article-title":"Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre","volume":"160","author":"Warren","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2024.11.015_bib0225","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/14737167.2018.1512408","article-title":"Adherence and resource use among psoriasis patients treated with biologics","volume":"18","author":"Aleshaki","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.ad.2024.11.015_bib0230","first-page":"e14486","article-title":"Ixekizumab in the treatment of moderate-to-severe plaque psoriasis: patient adherence, satisfaction, and preferences","volume":"34","author":"Aaminah","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2024.11.015_bib0235","series-title":"Lo que debes saber sobre la adherencia al tratamiento","first-page":"38","author":"Ibarra Barrueta","year":"2017"},{"key":"10.1016\/j.ad.2024.11.015_bib0240","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ad.2022.05.029","article-title":"Evaluaci\u00f3n de los resultados del \u00edndice de calidad de vida en Dermatolog\u00eda (DLQI) en pacientes con diagn\u00f3stico de psoriasis: un estudio transversal y de correlaci\u00f3n durante un periodo de 6 a\u00f1os","volume":"114","author":"Guavita Falla","year":"2023","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2024.11.015_bib0245","series-title":"Factores implicados en la adherencia terap\u00e9utica en la artritis reumatoide: impacto de la percepci\u00f3n del paciente","first-page":"109","author":"Ahij\u00f3n Lana","year":"2020"},{"key":"10.1016\/j.ad.2024.11.015_bib0250","first-page":"846","article-title":"La satisfacci\u00f3n con el tratamiento y la calidad de vida en pacientes con psoriasis pueden no estar directamente asociados. Estudio preliminar","volume":"89","author":"Delgado-Borja","year":"2021","journal-title":"Cir Cir"},{"key":"10.1016\/j.ad.2024.11.015_bib0255","first-page":"18","article-title":"Antirreum\u00e1ticos con diana: biol\u00f3gicos, biosimilares y dirigido","volume":"34","author":"Mingorance Ballesteros","year":"2019","journal-title":"BTA"},{"key":"10.1016\/j.ad.2024.11.015_bib0260","series-title":"Impacto de la calidad de vida de los pacientes psori\u00e1sicos de consultas externas del Hospital Militar G\u00f3mez Ulla de Madrid","first-page":"127","author":"Hernandez Garc\u00eda","year":"2015"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024009050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024009050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T09:20:58Z","timestamp":1738401658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731024009050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0001731024009050"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2024.11.015","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Psoriatic Patient-Reported Outcomes, Adherence, and Satisfaction","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2024.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2024.05.021","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}